Variant report

Variant	esv11642
Chromosome Location	chr19:41495414-41525937
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:208)
CpG islands
(count:733)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:208 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41507311-41507499	K562	blood:	n/a	n/a
2	ARID3A	chr19:41506351-41506450	HepG2	liver:	n/a	n/a
3	ATF3	chr19:41506069-41506786	HCT-116	colon:	n/a	n/a
4	ATF3	chr19:41506140-41506734	HCT-116	colon:	n/a	n/a
5	ATF3	chr19:41506267-41506508	K562	blood:	n/a	n/a
6	BHLHE40	chr19:41507420-41507421	K562	blood:	n/a	n/a
7	CBX3	chr19:41505993-41506787	HCT-116	colon:	n/a	n/a
8	CEBPB	chr19:41507207-41507407	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr19:41506268-41506934	HepG2	liver:	n/a	chr19:41506435-41506446
10	CEBPB	chr19:41507152-41507489	K562	blood:	n/a	n/a
11	CEBPB	chr19:41506244-41506603	ECC-1	luminal epithelium:	n/a	chr19:41506435-41506446
12	CEBPB	chr19:41506068-41507138	HCT-116	colon:	n/a	chr19:41506435-41506446
13	CEBPB	chr19:41506189-41507135	A549	lung:	n/a	chr19:41506435-41506446
14	CEBPB	chr19:41506284-41507442	A549	lung:	n/a	chr19:41506435-41506446
15	CEBPB	chr19:41506256-41506628	Hela-S3	cervix:	n/a	chr19:41506435-41506446
16	CEBPB	chr19:41506263-41507465	K562	blood:	n/a	chr19:41506435-41506446
17	CEBPB	chr19:41505976-41507518	HCT-116	colon:	n/a	chr19:41506435-41506446
18	CEBPB	chr19:41506884-41506987	IMR90	lung:	n/a	n/a
19	CEBPB	chr19:41506208-41506618	A549	lung:	n/a	chr19:41506435-41506446
20	CEBPB	chr19:41506205-41506669	MCF-7	breast:	n/a	chr19:41506435-41506446
21	CREB1	chr19:41507218-41507529	K562	blood:	n/a	n/a
22	CTCF	chr19:41507196-41507510	K562	blood:	n/a	n/a
23	CTCF	chr19:41507222-41507435	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr19:41507200-41507350	RPTEC	kidney:	n/a	n/a
25	CTCF	chr19:41507300-41507450	WERI-Rb-1	eye:	n/a	n/a
26	CTCF	chr19:41507260-41507410	MCF-7	breast:	n/a	n/a
27	CTCF	chr19:41510420-41510570	K562	blood:	n/a	n/a
28	CTCF	chr19:41507200-41507350	A549	lung:	n/a	n/a
29	CTCF	chr19:41515007-41515108	MCF-7	breast:	n/a	n/a
30	CTCF	chr19:41507297-41507364	NHEK	skin:	n/a	n/a
31	CTCF	chr19:41518660-41518829	MCF-7	breast:	n/a	chr19:41518752-41518762 chr19:41518750-41518763 chr19:41518747-41518765
32	CTCF	chr19:41507305-41507354	GM12891	blood:	n/a	n/a
33	CTCF	chr19:41507302-41507365	A549	lung:	n/a	n/a
34	CTCF	chr19:41507240-41507390	A549	lung:	n/a	n/a
35	CTCF	chr19:41507257-41507415	HepG2	liver:	n/a	n/a
36	CTCF	chr19:41507248-41507425	MCF-7	breast:	n/a	n/a
37	CTCF	chr19:41518700-41518850	HCT-116	colon:	n/a	chr19:41518752-41518762 chr19:41518750-41518763 chr19:41518747-41518765
38	CTCF	chr19:41507300-41507450	HEK293	kidney:	n/a	n/a
39	CTCF	chr19:41507194-41507507	MCF-7	breast:	n/a	n/a
40	CTCF	chr19:41507246-41507415	Gliobla	brain:	n/a	n/a
41	CTCF	chr19:41507220-41507370	K562	blood:	n/a	n/a
42	CTCF	chr19:41507142-41507427	K562	blood:	n/a	n/a
43	CTCF	chr19:41507215-41507476	K562	blood:	n/a	n/a
44	CTCF	chr19:41507225-41507473	K562	blood:	n/a	n/a
45	CTCF	chr19:41507237-41507437	MCF-7	breast:	n/a	n/a
46	CTCF	chr19:41507249-41507410	MCF-7	breast:	n/a	n/a
47	CTCF	chr19:41507280-41507430	WERI-Rb-1	eye:	n/a	n/a
48	CTCF	chr19:41507112-41507508	K562	blood:	n/a	n/a
49	CTCF	chr19:41507320-41507470	HCT-116	colon:	n/a	n/a
50	CTCF	chr19:41507134-41507522	A549	lung:	n/a	n/a

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41524298-41524348	HCM	heart:	n/a
2	chr19:41524298-41524348	HCM	heart:	n/a
3	chr19:41496749-41496799	LNCaP	prostate:	n/a
4	chr19:41496043-41496093	RPTEC	kidney:	n/a
5	chr19:41497222-41497272	HRPEpiC	eye:	n/a
6	chr19:41510059-41510109	BJ	skin:	n/a
7	chr19:41496749-41496799	GM12892	blood:	n/a
8	chr19:41524298-41524348	HCF	heart:	n/a
9	chr19:41510026-41510076	HRCEpiC	kidney:	n/a
10	chr19:41510243-41510293	A549	lung:	n/a
11	chr19:41496749-41496799	ProgFib	skin:	n/a
12	chr19:41497222-41497272	SK-N-SH	brain:	n/a
13	chr19:41496043-41496093	IMR90	lung:	fetal
14	chr19:41510098-41510148	SK-N-SH_RA	brain:	n/a
15	chr19:41496043-41496093	MCF-7	breast:	n/a
16	chr19:41510243-41510293	HRPEpiC	eye:	n/a
17	chr19:41497222-41497272	HMEC	breast:	n/a
18	chr19:41497222-41497272	NHBE	bronchial:	n/a
19	chr19:41510037-41510087	LNCaP	prostate:	n/a
20	chr19:41496749-41496799	Hela-S3	cervix:	n/a
21	chr19:41510059-41510109	HCM	heart:	n/a
22	chr19:41510272-41510322	HL-60	blood:	n/a
23	chr19:41510243-41510293	LNCaP	prostate:	n/a
24	chr19:41524298-41524348	AG09309	skin:	n/a
25	chr19:41510059-41510109	SKMC	muscle:	n/a
26	chr19:41496043-41496093	AG04449	skin:	fetal
27	chr19:41497222-41497272	GM12891	blood:	n/a
28	chr19:41510037-41510087	H1-hESC	embryonic stem cell:	embryo
29	chr19:41510059-41510109	MCF10A-Er-Src	breast:	n/a
30	chr19:41510285-41510335	HIPEpiC	eye:	n/a
31	chr19:41510098-41510148	BJ	skin:	n/a
32	chr19:41510059-41510109	AG09309	skin:	n/a
33	chr19:41496749-41496799	HCT-116	colon:	n/a
34	chr19:41510037-41510087	Hela-S3	cervix:	n/a
35	chr19:41510285-41510335	SAEC	small airway:	n/a
36	chr19:41497222-41497272	SK-N-SH_RA	brain:	n/a
37	chr19:41510098-41510148	NHDF-neo	bronchial:	n/a
38	chr19:41510285-41510335	HCT-116	colon:	n/a
39	chr19:41510272-41510322	A549	lung:	n/a
40	chr19:41510285-41510335	AG04450	lung:	fetal
41	chr19:41496043-41496093	T-47D	breast:	n/a
42	chr19:41496749-41496799	GM19239	blood:	n/a
43	chr19:41510243-41510293	AG09309	skin:	n/a
44	chr19:41496749-41496799	AG09319	gingival:	n/a
45	chr19:41510285-41510335	HUVEC	blood vessel:	n/a
46	chr19:41510285-41510335	ovcar-3	ovarian:	n/a
47	chr19:41510285-41510335	NH-A	brain:	n/a
48	chr19:41510037-41510087	MCF-7	breast:	n/a
49	chr19:41510026-41510076	IMR90	lung:	fetal
50	chr19:41510026-41510076	AG09319	gingival:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2B6-1	chr19:41503762-41503928	l_1687_chr19:41492503-41503928_testes

No data

Variant related genes	Relation type
CYP2B6	TF binding region
CYP2B6	CpG island

Extended variants
information (count: 1884 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:1884 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3760657	chr19:41495433-41495434	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs554992743	chr19:41495437-41495438	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs150173239	chr19:41495442-41495443	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs181751752	chr19:41495466-41495467	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs572025401	chr19:41495560-41495561	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs540168162	chr19:41495563-41495564	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs553979142	chr19:41495574-41495575	Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs12721652	chr19:41495633-41495634	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs111386238	chr19:41495639-41495640	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs557763084	chr19:41495647-41495648	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs147813000	chr19:41495655-41495656	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs141374289	chr19:41495671-41495672	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs563120063	chr19:41495673-41495674	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs533618477	chr19:41495674-41495675	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs114116842	chr19:41495707-41495708	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs186498984	chr19:41495721-41495722	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs111930595	chr19:41495722-41495723	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs138038979	chr19:41495731-41495732	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs149453494	chr19:41495738-41495739	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs143008826	chr19:41495745-41495746	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs2054675	chr19:41495755-41495756	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs538524057	chr19:41495802-41495803	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs148199237	chr19:41495808-41495809	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs565865949	chr19:41495815-41495816	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs141973461	chr19:41495834-41495835	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs146156466	chr19:41495838-41495839	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs191290616	chr19:41495840-41495841	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs138959280	chr19:41495844-41495845	Flanking Active TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs556752962	chr19:41495856-41495857	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs578226478	chr19:41495868-41495869	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs142193743	chr19:41495983-41495984	Flanking Active TSS Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs12721648	chr19:41495987-41495988	Flanking Active TSS Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs146327215	chr19:41496007-41496008	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs139326108	chr19:41496008-41496009	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs4802100	chr19:41496025-41496026	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs542433525	chr19:41496077-41496078	Flanking Active TSS Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs531654529	chr19:41496087-41496088	Flanking Active TSS Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs549880274	chr19:41496090-41496091	Flanking Active TSS Weak transcription Enhancers	CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs150014282	chr19:41496102-41496103	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs543042986	chr19:41496116-41496117	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs574119497	chr19:41496123-41496124	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs182372168	chr19:41496145-41496146	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs144219969	chr19:41496237-41496238	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs565951601	chr19:41496238-41496239	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs536196980	chr19:41496261-41496262	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs548159552	chr19:41496264-41496265	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs376341780	chr19:41496291-41496292	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs77221680	chr19:41496292-41496293	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs75255151	chr19:41496293-41496294	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs71175662	chr19:41496315-41496316	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:103 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41490600-41495800	Weak transcription	Rectal Mucosa Donor 31	rectum
2	chr19:41495200-41496200	Flanking Active TSS	Liver	Liver
3	chr19:41495600-41495800	Enhancers	Duodenum Mucosa	Duodenum
4	chr19:41495600-41495800	Bivalent Enhancer	K562	blood
5	chr19:41495800-41496400	Weak transcription	Duodenum Mucosa	Duodenum
6	chr19:41495800-41497800	Enhancers	Rectal Mucosa Donor 31	rectum
7	chr19:41496200-41496400	Enhancers	Liver	Liver
8	chr19:41496400-41497000	Flanking Active TSS	Liver	Liver
9	chr19:41496400-41497800	Enhancers	Duodenum Mucosa	Duodenum
10	chr19:41496600-41498200	Enhancers	Stomach Mucosa	stomach
11	chr19:41496800-41497200	Active TSS	Rectal Mucosa Donor 29	rectum
12	chr19:41496800-41497200	Enhancers	A549	lung
13	chr19:41496800-41499200	Enhancers	Fetal Intestine Small	intestine
14	chr19:41497000-41497200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
15	chr19:41497000-41499400	Active TSS	Liver	Liver
16	chr19:41497200-41497400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
17	chr19:41497200-41497600	Enhancers	Colonic Mucosa	Colon
18	chr19:41497400-41497600	Enhancers	Rectal Mucosa Donor 29	rectum
19	chr19:41497400-41497800	Enhancers	Sigmoid Colon	Sigmoid Colon
20	chr19:41497400-41500200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr19:41499200-41501600	Weak transcription	Fetal Intestine Small	intestine
22	chr19:41499400-41499600	Flanking Active TSS	Liver	Liver
23	chr19:41499600-41501400	Transcr. at gene 5' and 3'	Liver	Liver
24	chr19:41501400-41502200	Active TSS	Liver	Liver
25	chr19:41501600-41502400	Enhancers	Fetal Intestine Small	intestine
26	chr19:41502200-41503600	Weak transcription	Liver	Liver
27	chr19:41502400-41505600	Weak transcription	Fetal Intestine Small	intestine
28	chr19:41503600-41504200	Genic enhancers	Liver	Liver
29	chr19:41504200-41505600	Weak transcription	Liver	Liver
30	chr19:41505600-41506200	Enhancers	Stomach Mucosa	stomach
31	chr19:41505600-41508000	Genic enhancers	Liver	Liver
32	chr19:41505600-41509400	Enhancers	Fetal Intestine Small	intestine
33	chr19:41505800-41506400	Enhancers	Duodenum Mucosa	Duodenum
34	chr19:41505800-41506400	Flanking Active TSS	A549	lung
35	chr19:41505800-41506600	Enhancers	HMEC	breast
36	chr19:41505800-41507400	Enhancers	Fetal Intestine Large	intestine
37	chr19:41506000-41506200	Bivalent Enhancer	Small Intestine	intestine
38	chr19:41506000-41506400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr19:41506000-41506400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr19:41506200-41506400	Enhancers	K562	blood
41	chr19:41506200-41506600	Enhancers	Hela-S3	cervix
42	chr19:41506400-41506600	Enhancers	A549	lung
43	chr19:41506400-41507600	Weak transcription	K562	blood
44	chr19:41506400-41509000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr19:41506400-41509200	Weak transcription	Duodenum Mucosa	Duodenum
46	chr19:41506600-41509400	Weak transcription	A549	lung
47	chr19:41506800-41507000	Enhancers	H9 Cell Line	embryonic stem cell
48	chr19:41507000-41507200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
49	chr19:41507400-41509000	Weak transcription	Fetal Intestine Large	intestine
50	chr19:41507400-41529200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links